Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 9/20 | 0.61 |
| ▸ | DRD3 known ✓ | P35462 | 6/20 | 0.61 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 2/20 | 0.61 |
| ▸ | DRD4 known ✓ | P21917 | 2/20 | 0.55 |
| ▸ | DRD1 | P21728 | 13/20 | 0.61 |
| ▸ | F3 | P13726 | 9/20 | 0.61 |
| ▸ | DRD5 | P21918 | 5/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL910623 | 1.00 | DRD1 (0.61) | DRD1DRD2F3DRD3DRD5 | |
| Cadaverine Tartrate SCHEMBL910404 | 0.95 | DRD1 (0.61) | DRD1DRD2F3DRD3DRD5 | |
| SCHEMBL910355 | 0.93 | DRD1 (0.70) | DRD1DRD2F3DRD3DRD5 | |
| SCHEMBL29999932 | 0.93 | DRD1 (0.70) | DRD1DRD2F3DRD3DRD5 | |
| Sulfuric Acid SCHEMBL29999956 | 0.92 | DRD1 (0.67) | DRD1DRD2F3DRD3DRD5 | |
| Sulfuric Acid SCHEMBL910891 | 0.92 | DRD1 (0.67) | DRD1DRD2F3DRD3DRD5 | |
| Hydrochloric Acid SCHEMBL30000488 | 0.92 | LMNA (0.71) | DRD1DRD2F3DRD3DRD5 | |
| Hydrochloric Acid SCHEMBL910111 | 0.92 | LMNA (0.71) | DRD1DRD2F3DRD3DRD5 | |
| Phosphoric Acid SCHEMBL29999988 | 0.91 | DRD1 (0.64) | DRD1DRD2F3DRD3DRD5 | |
| Phosphoric Acid SCHEMBL910139 | 0.91 | DRD1 (0.64) | DRD1DRD2F3DRD3DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220387403-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY | CVI PHARMACEUTICALS LIMITED (KY) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387403-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY | LIPC, FABP1, CPT1A | DRD2 4557/4885DRD3 4182/4885SIGMAR1 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.